Product Information
QUETIAPINE ER 50 MG TABLET is a generic product labeled by BluePoint Laboratories, priced at $0.1099 per EA under NDC 68001051106. Its NADAC has been published 208 times since Mar 9, 2022.
FDA first approved this application on Nov 29, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
50 mg/1
Manufacturer
BluePoint LaboratoriesNDC
68001051106
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Effective Date
2/18/2026
Active Ingredients
QUETIAPINE FUMARATEApproval Type
Generic (ANDA)
FDA Application
ANDA206252FDA Approved
11/29/2017
TE Code
AB
On Market Since
8/31/2021
Pharmacological Classes
Price Statistics
The NADAC for QUETIAPINE ER 50 MG TABLET has been published 208 times since Mar 9, 2022, and over the history we have for it it has declined 37.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1099 per EA |
|---|---|
| All-time high | $0.1892 (Jul 13, 2022) |
| All-time low | $0.0912 (Apr 17, 2024) |
| 52-week high | $0.1161 |
| 52-week low | $0.1082 |
| Median price | $0.1242 |
| Average price | $0.1299 |
| Largest weekly change | +37.6% (Aug 21, 2024) |
| Weeks tracked | 208 |
| Tracking since | Mar 9, 2022 |
1W
N/A
1M
N/A
3M
N/A
6M
0.0%
1Y
-5.3%
3Y
-30.6%
5Y
N/A
All
-37.2%
Last surveyed Feb 25, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of QUETIAPINE ER 50 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for QUETIAPINE ER 50 MG TABLET, manufactured by BluePoint Laboratories, is $0.1099 per EA (NDC 68001051106), effective Feb 25, 2026.
How has the price of QUETIAPINE ER 50 MG TABLET changed over time?
Over the history we have for it, the NADAC for QUETIAPINE ER 50 MG TABLET has declined 37.2%. It has been tracked across 208 weekly CMS publications since Mar 9, 2022.
What are the highest and lowest recorded NADAC prices for QUETIAPINE ER 50 MG TABLET?
Since Mar 9, 2022, the NADAC for QUETIAPINE ER 50 MG TABLET has ranged from a low of $0.0912 (Apr 17, 2024) to a high of $0.1892 (Jul 13, 2022), with a median of $0.1242 per EA.
Are there cheaper alternatives to QUETIAPINE ER 50 MG TABLET?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as QUETIAPINE ER 50 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures QUETIAPINE ER 50 MG TABLET?
QUETIAPINE ER 50 MG TABLET (NDC 68001051106) is labeled by BluePoint Laboratories, and CMS classifies it as a generic product.